Trial intelligence / Profile preview

Preoperative Chemoradiation and Adjuvant Chemotherapy in Esophageal Cancer

NCT00230451Phase 2Completed

Sponsor
University of Michigan Rogel Cancer Center
Start
Nov 1997
Primary completion
Dec 1999
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, cisplatin, fluorouracil in esophageal cancer, sponsored by University of Michigan Rogel Cancer Center. Started Nov 1997; status: completed.

02

Drugs

paclitaxelcisplatinfluorouracil
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00230451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00230451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call